natgillin/translations-raw huggingface dataset:
In the light of the findings of the assessment report, it is appropriate to require that specific risk mitigation measures are applied at product authorisation level to products containing flocoumafen and used as rodenticides.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se pri izdaji dovoljenja za pripravke, ki vsebujejo flokumafen in se uporabljajo kot rodenticidi, uporabijo posebni ukrepi za zmanjšanje tveganja.
In view of the identified risks and its characteristics, which render it potentially persistent, liable to bioaccumulate and toxic, or very persistent and very liable to bioaccumulate, flocoumafen should be included in Annex I for five years only and should be made subject to a comparative risk assessment in accordance with the second subparagraph of Article 10(5)(i) of Directive 98/8/EC before its inclusion in Annex I is renewed.
Zaradi ugotovljenih tveganj in značilnosti flokumafena, ki je potencialno obstojen, se lahko kopiči v organizmih in je strupen ali zelo obstojen ter se zelo lahko kopiči v organizmih, ga je treba vključiti v Prilogo I samo za pet let, pred njegovo ponovno vključitvijo pa je treba v skladu z drugim pododstavkom člena 10(5)(i) Direktive 98/8/ES izvesti primerljivo oceno tveganja.
It is important that the provisions of this Directive be applied simultaneously in all the Member States in order to ensure equal treatment of biocidal products on the market containing the active substance flocoumafen and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki na trgu, ki vsebujejo aktivno snov flokumafen, in da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC, and in particular, to grant, modify or cancel authorisations of biocidal products in product-type 14 containing flocoumafen to ensure that they comply with Directive 98/8/EC.
Državam članicam je treba po vključitvi zagotoviti ustrezno obdobje za izvedbo člena 16(3) Direktive 98/8/ES in zlasti za izdajo, spremembo ali razveljavitev dovoljenj za biocidne pripravke v 14. vrsti izdelkov, ki vsebujejo flokumafen, da se zagotovi njihova skladnost z Direktivo 98/8/ES.
Member States shall adopt and publish, by 30 September 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice najpozneje do 30. septembra 2010 sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo.
They shall apply those provisions from 1 October 2011.
Navedene predpise uporabljajo od 1. oktobra 2011.
The following entry ‘No 31’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 31“:
4-hydroxy-3-[(1RS,3RS;1RS,3RS)-1,2,3,4-tetrahydro-3-[4-(4-trifluoromethylbenzyloxy)phenyl]-1-naphthyl]coumarin
4-hidroksi-3-[(1RS,3RS;1RS,3RS)-1,2,3,4-tetrahidro-3-[4-(4-trifluorometilbenziloksi)fenil]-1-naftil)]kumarin
EC No 421-960-0
Št. ES: 421-960-0
CAS No 90035-08-8
Št. CAS: 90035-08-8
1 October 2011
1. oktober 2011
The nominal concentration of the active substance in products shall not exceed 50 mg/kg and only ready-for-use products shall be authorised.
Nazivna koncentracija aktivne snovi v pripravkih ne presega 50 mg/kg, dovoljenje pa se izda samo za pripravke, ki se lahko takoj uporabijo.
Products shall contain an aversive agent and, where appropriate, a dye.
Pripravki morajo vsebovati averzivno sredstvo in po potrebi barvilo.
Products shall not be used as tracking powder.
Pripravki se ne smejo uporabljati kot sredstvo za posipanje.
Those include, amongst others, the restriction to professional use only, setting an upper limit to the package size and laying down obligations to use tamper resistant and secured bait boxes.’
Ti med drugim vključujejo omejitev uporabe pripravka na zgolj poklicno, določitev največje velikosti embalaže in določitev zahtev za uporabo vab, zaščitenih pred nepooblaščenimi posegi.“
Commission Directive 2009/151/EC
Direktiva Komisije 2009/151/ES
amending Directive 98/8/EC of the European Parliament and of the Council to include tolylfluanid as an active substance in Annex I thereto
o spremembi Direktive 98/8/ES Evropskega parlamenta in Sveta za vključitev tolilfluanida kot aktivne snovi v Prilogo I k Direktivi
Pursuant to Regulation (EC) No 1451/2007, tolylfluanid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 8, wood preservatives, as defined in Annex V to Directive 98/8/EC.
Na podlagi Uredbe (ES) št. 1451/2007 je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja tolilfluanida glede uporabe v 8. vrsti izdelkov, pripravkih za zaščito lesa, kot je določena v Prilogi V k Direktivi 98/8/ES.
Finland was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 24 April 2006 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Finska, ki je bila imenovana za državo članico poročevalko, je 24. aprila 2006 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from the examinations made that biocidal products used as wood preservatives and containing tolylfluanid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Preiskave so pokazale, da je za biocidne pripravke, ki se uporabljajo kot pripravki za zaščito lesa in vsebujejo tolilfluanid, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to include tolylfluanid in Annex I, in order to ensure that in all Member States authorisations for biocidal products used as wood preservatives and containing tolylfluanid can be granted, modified, or cancelled in accordance with Article 16(3) of Directive 98/8/EC.
Zato je primerno vključiti tolilfluanid v Prilogo I, da se v vseh državah članicah v skladu s členom 16(3) Direktive 98/8/ES zagotovi, da se izdajo, spremenijo ali razveljavijo dovoljenja za biocidne pripravke, ki se uporabljajo kot pripravki za zaščito lesa in vsebujejo tolilfluanid.
Therefore, products containing tolylfluanid and used as wood preservatives should not be authorised for those uses.
Zato se uporaba pripravkov, ki vsebujejo tolilfluanid in se uporabljajo kot pripravki za zaščito lesa, v te namene ne dovoli.
In the light of the findings of the assessment report, it is appropriate to require that risk mitigation measures are applied at product authorisation level to products containing tolylfluanid and used as wood preservatives to ensure that risks are reduced to an acceptable level in accordance with Article 5 of Directive 98/8/EC and Annex VI thereto.
Glede na ugotovitve poročila o oceni je primerno zahtevati, da se v skladu s členom 5 Direktive 98/8/ES in Priloge VI k Direktivi pri izdaji dovoljenj za pripravke, ki vsebujejo tolilfluanid in se uporabljajo za zaščito lesa, uporabijo ukrepi za zmanjšanje tveganja, da se tveganje zmanjša na sprejemljivo raven.
In particular, it is appropriate to require that products intended for industrial or professional use be used with appropriate protective equipment unless it can be demonstrated that risks for industrial or professional users can be reduced by other means.
Zlasti je primerno zahtevati, da se pripravki, namenjeni industrijski ali poklicni uporabi, uporabljajo z ustrezno zaščitno opremo, razen če se lahko dokaže, da je tveganje za industrijske ali poklicne uporabnike mogoče kako drugače zmanjšati.
Appropriate measures should be taken to protect the soil and aquatic compartments since unacceptable risks to these compartments have been identified during the evaluation.
Treba je sprejeti ustrezne ukrepe za varovanje tal in vode, saj je bilo med presojo ugotovljeno nesprejemljivo tveganje za ta ekosistema.
Instructions should therefore be provided to indicate that treated timber must be stored after treatment under shelter and/or on impermeable hard standing and that any losses must be collected for reuse or disposal.
Zato se predložijo navodila, v katerih bo navedeno, da je treba obdelani les po obdelavi hraniti pod streho in/ali na neprepustni trdni podlagi in omogočiti zbiranje pripravkov za ponovno uporabo ali odstranitev.
It is important that the provisions of this Directive be applied simultaneously in all the Member States in order to ensure equal treatment of biocidal products on the market containing the active substance tolylfluanid and also to facilitate the proper operation of the biocidal products market in general.
Pomembno je, da se določbe te direktive uporabljajo hkrati v vseh državah članicah, da se zagotovi enako ravnanje z biocidnimi pripravki na trgu, ki vsebujejo aktivno snov tolilfluanid, in da se omogoči ustrezno delovanje trga biocidnih pripravkov na splošno.
After inclusion, Member States should be allowed a reasonable period to implement Article 16(3) of Directive 98/8/EC, and in particular, to grant, modify or cancel authorisations of biocidal products in product-type 8 containing tolylfluanid to ensure that they comply with Directive 98/8/EC.
Državam članicam je treba po vključitvi zagotoviti ustrezno obdobje za izvedbo člena 16(3) Direktive 98/8/ES in zlasti za izdajo, spremembo ali razveljavitev dovoljenj za biocidne pripravke v 8. vrsti izdelkov, ki vsebujejo tolilfluanid, da se zagotovi njihova skladnost z Direktivo 98/8/ES.
Member States shall adopt and publish, by 30 September 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. septembra 2010.
The following entry ‘No 29’ is inserted in Annex I to Directive 98/8/EC:
V Prilogo I k Direktivi 98/8/ES se vstavi naslednji vnos „št. 29“:
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide
dikloro-N-[(dimetilamino)sulfonil]fluoro-N-(p-tolil)metansulfenamid
EC No: 211-986-9
št. ES: 211-986-9
CAS No: 731-27-1
št. CAS: 731-27-1
30 September 2021
30. september 2021
Products shall not be authorised for the in situ treatment of wood outdoors or for wood that will be exposed to weathering.
Uporaba pripravkov se ne dovoli za obdelavo lesa na prostem na kraju samem ali za les, ki bo izpostavljen vremenskim vplivom.
In view of the assumptions made during the risk assessment, products authorised for industrial or professional use must be used with appropriate personal protective equipment, unless it can be demonstrated in the application for product authorisation that risks to industrial or professional users can be reduced to an acceptable level by other means.
Glede na ugotovitve ocene tveganja je treba pripravke z dovoljenjem za industrijsko ali poklicno uporabo uporabljati z ustrezno osebno zaščitno opremo, razen če se v vlogi za izdajo dovoljenja za pripravek lahko dokaže, da je tveganje za industrijske ali poklicne uporabnike mogoče kako drugače zmanjšati na sprejemljivo raven.
In view of the risks identified for the soil and aquatic compartments, appropriate risk mitigation measures must be taken to protect those compartments.
Zaradi ugotovljenega tveganja za tla in vodo je treba za varovanje teh ekosistemov sprejeti ustrezne ukrepe za zmanjšanje tveganja.
In particular, labels and/or safety-data sheets of products authorised for industrial or professional use shall indicate that freshly treated timber must be stored after treatment under shelter and/or on impermeable hard standing to prevent direct losses to soil or water and that any losses must be collected for reuse or disposal.’
Zlasti se na oznakah in/ali varnostnih listih pripravkov, katerih uporaba je dovoljena v industriji ali za poklicno uporabo, navede, da je treba sveže obdelani les po obdelavi hraniti pod streho in/ali na neprepustni trdni podlagi, da se prepreči neposredno spiranje pripravkov v tla ali vodo, in da je treba omogočiti njihovo zbiranje za ponovno uporabo ali odstranitev.“
tolylfluanid
tolilfluanid
Commission Directive 2009/152/EC
Direktiva Komisije 2009/152/ES
amending Council Directive 91/414/EEC as regards the expiry date for inclusion in Annex I of the active substance carbendazim
o spremembi Direktive Sveta 91/414/EGS v zvezi z datumom poteka veljavnosti za vključitev aktivne snovi karbendazim v Prilogo I
By Commission Directive 2006/135/EC [2] carbendazim was included as an active substance in Annex I to Directive 91/414/EEC.
Z Direktivo Komisije 2006/135/ES [2] je bila aktivna snov karbendazim vključena v Prilogo I k Direktivi 91/414/EGS.
That inclusion expires on 31 December 2009.
Navedena vključitev preneha veljati 31. decembra 2009.
On request the inclusion of an active substance may be renewed for a period not exceeding 10 years.
Vključitev aktivne snovi se na zahtevo lahko podaljša za največ deset let.
On 6 August 2007 the Commission received such a request from the notifier regarding the renewal of the inclusion for this substance.
Komisija je 6. avgusta 2007 od prijavitelja prejela zahtevek, ki se je nanašal na podaljšanje vključitve za to snov.
On 10 January 2008 the notifier submitted a technical dossier to the rapporteur Member State Germany in support of its request.
Prijavitelj je zahtevek podprl s tehnično dokumentacijo, ki jo je 10. januarja 2008 predložil državi članici poročevalki, tj. Nemčiji.
Germany delivered its draft reassessment report on 27 July 2009.
Nemčija je 27. julija 2009 predstavila osnutek poročila o oceni.
It is necessary that the European Food Safety Authority performs a peer review.
Evropska agencija za varnost hrane pa mora opraviti še strokovni pregled.
Since it is impossible to complete the renewal procedure before the date when the inclusion of carbendazim will expire and since the request for renewal was made in sufficient time, in accordance with Article 5(5) of Directive 91/414/EEC a renewal should be granted for the period necessary to complete that procedure.
Ker postopka za podaljšanje ni mogoče končati pred datumom izteka veljavnosti za vključitev karbendazima in je bil zahtevek za podaljšanje vložen pravočasno, je treba v skladu z členom 5(5) Direktive 91/414/EGS odobriti obdobje, ki je potrebno za končanje navedenega postopka.
In Annex I to Directive 91/414/EEC, in row No 149 (carbendazim (unstated stereochemistry) CAS No 10605-21-7 CIPAC No 263), in the sixth column (expiration of inclusion), the words ‘31 December 2009’ are replaced by the words ‘31 December 2010’.
V Prilogi I k Direktivi 91/414/EGS se v vrstici št. 149 (karbendazim (stereokemija ni navedena) št. CAS 10605-21-7, št. CIPAC 263) v šestem stolpcu (veljavnost registracije) „31. december 2009“ nadomesti z „31. december 2010“.
Member States shall adopt and publish by 31 December 2009 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 31. decembra 2009.
OJ L 349, 12.12.2006, p. 37.
UL L 349, 12.12.2006, str. 37.
Commission Directive 2009/153/EC
Direktiva Komisije 2009/153/ES
amending Annex I to Council Directive 91/414/EEC as regards the common name and the purity of the active substance hydrolysed proteins
o spremembi Priloge I k Direktivi Sveta 91/414/EGS glede splošnega imena in čistosti hidroliziranih beljakovin kot aktivnih snovi
Directive 91/414/EEC was amended by Commission Directive 2008/127/EC [2] to include certain hydrolysed proteins.
Direktiva 91/414/EGS je bila spremenjena z Direktivo Komisije 2008/127/ES [2], s katero so bile vključene nekatere hidrolizirane beljakovine.
The rapporteur Member State has received additional information on hydrolysed proteins.
Država članica poročevalka je prejela dodatne informacije o hidroliziranih beljakovinah.
It appears that hydrolysed proteins can be originated by many different organic compounds.
Videti je, da hidrolizirane beljakovine lahko izvirajo iz številnih različnih organskih spojin.
It is therefore appropriate to refer to the common name and purity specifications, as set out in the review report on hydrolysed proteins.
Zato se je primerno sklicevati na splošno ime in specifikacije čistosti, kakor je določeno v poročilu o pregledu glede hidroliziranih beljakovin.
Directive 91/414/EEC should therefore be amended accordingly.
Direktivo 91/414/EGS je zato treba ustrezno spremeniti.
Annex I to Directive 91/414/EEC is amended in accordance with the Annex to this Directive.
Priloga I k Direktivi 91/414/EGS se spremeni v skladu s Prilogo k tej direktivi.
Member States shall adopt and publish, by 28 February 2010 at the latest, the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 28. februarja 2010.
OJ L 344, 20.12.2008, p. 89.
UL L 344, 20.12.2008, str. 89.
In Annex I to Directive 91/414/EEC, row No 240 is replaced by the following:
V Prilogi I k Direktivi 91/414/EGS se vrstica št. 240 nadomesti z naslednjim:
Hydrolysed proteins
Hidrolizirane beljakovine
Review report (SANCO/2615/2008)
Poročilo o pregledu (SANCO/2615/2008)
31 August 2019
31. avgust 2019
Hydrolysed proteins of animal origin must be in compliance with Regulation (EC) No 1774/2002.
Hidrolizirane beljakovine živalskega izvora morajo biti v skladu z Uredbo (ES) št. 1774/2002.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on hydrolysed proteins (SANCO/2615/2008) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za hidrolizirane beljakovine (SANCO/2615/2008) ter zlasti dodatkov I in II h končni različici poročila, ki jo je pripravil Stalni odbor za prehranjevalno verigo in zdravje živali.
Commission Directive 2009/154/EC
Direktiva Komisije 2009/154/ES
amending Council Directive 91/414/EEC to include cyflufenamid as active substance
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve ciflufenamida kot aktivne snovi
In accordance with Article 6(2) of Directive 91/414/EEC the United Kingdom received on 17 March 2003 an application from Nisso Chemical Europe GmbH for the inclusion of the active substance cyflufenamid in Annex I to Directive 91/414/EEC.
V skladu s členom 6(2) Direktive 91/414/EGS je Velika Britanija 17. marca 2003 od družbe Nisso Chemical Europe GmbH prejela vlogo za vključitev aktivne snovi ciflufenamid v Prilogo I k Direktivi 91/414/EGS.
Commission Decision 2003/636/EC [2] confirmed that the dossier was complete in the sense that it could be considered as satisfying, in principle, the data and information requirements of Annexes II and III to Directive 91/414/EEC.
Komisija je z Odločbo 2003/636/ES [2] potrdila, da je dokumentacija popolna v smislu načelnega izpolnjevanja zahtev po podatkih in informacijah iz prilog II in III k Direktivi 91/414/EGS.
For that active substance, the effects on human health and the environment have been assessed, in accordance with the provisions of Article 6(2) and (4) of Directive 91/414/EEC, for the uses proposed by the applicant.
Za to aktivno snov so bili ocenjeni vplivi na zdravje ljudi in okolje v skladu z določbami člena 6(2) in (4) Direktive 91/414/EGS za rabe, ki jih je predlagal vlagatelj.
The designated rapporteur Member State submitted a draft assessment report on 30 January 2006.
Država članica, ki je bila določena kot poročevalka, je 30. januarja 2006 predložila osnutek poročila o oceni.
The assessment report was peer reviewed by the Member States and the EFSA and presented to the Commission in the format of the EFSA Scientific Report for cyflufenamid on 8 April 2009 [3].
Poročilo o oceni so pregledali strokovnjaki držav članic in EFSA ter ga 8. aprila 2009 predložili Komisiji v obliki znanstvenega poročila EFSA o ciflufenamidu [3].
This report was reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 2 October 2009 in the format of the Commission review report for cyflufenamid.
To poročilo so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 2. oktobra 2009 v obliki poročila Komisije o pregledu glede ciflufenamida.
It has appeared from the various examinations made that plant protection products containing cyflufenamid may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) and Article 5(3) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo ciflufenamid, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) ter člena 5(3) Direktive 91/414/EGS, zlasti v zvezi z vrstami uporab, ki so bile preučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include cyflufenamid in Annex I to that Directive, in order to ensure that in all Member States the authorisations of plant protection products containing this active substance may be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti ciflufenamid v Prilogo I k navedeni direktivi, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo to aktivno snov.
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing provisional authorisations of plant protection products containing cyflufenamid to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should transform existing provisional authorisations into full authorisations, amend them or withdraw them in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti iz Direktive 91/414/EGS, ki izhajajo iz vključitve aktivne snovi v Prilogo I, je državam članicam treba omogočiti, da v šestih mesecih po vključitvi snovi pregledajo obstoječe začasne registracije fitofarmacevtskih sredstev, ki vsebujejo ciflufenamid, da zagotovijo izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice v skladu z določbami Direktive 91/414/EGS obstoječe začasne registracije po potrebi spremenijo v dokončne registracije, jih nadomestijo ali prekličejo.
Member States shall adopt and publish by 30 September 2010 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo najpozneje do 30. septembra 2010.
They shall apply those provisions from 1 October 2010.
Države članice uporabljajo navedene predpise od 1. oktobra 2010.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing cyflufenamid as active substance by 30 September 2010.
Države članice v skladu z Direktivo 91/414/EGS do 30. septembra 2010 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo ciflufenamid kot aktivno snov.